标题
Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide
作者
关键词
-
出版物
PROSTATE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-05-31
DOI
10.1002/pros.23661
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Current treatment strategies for advanced prostate cancer
- (2017) Kazumasa Komura et al. INTERNATIONAL JOURNAL OF UROLOGY
- Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity
- (2017) Francesca Bedussi et al. PHARMACOLOGY
- Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer
- (2016) Masaki Shiota et al. INTERNATIONAL JOURNAL OF UROLOGY
- Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7
- (2016) Masaki Shiota et al. JNCI-Journal of the National Cancer Institute
- Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7
- (2016) Masaki Shiota et al. JNCI-Journal of the National Cancer Institute
- Taxane Chemotherapy for Hormone-Naïve Prostate Cancer with Its Expanding Role as Breakthrough Strategy
- (2016) Masaki Shiota et al. Frontiers in Oncology
- Androgen–glucocorticoid interactions in the era of novel prostate cancer therapy
- (2015) Sujata Narayanan et al. Nature Reviews Urology
- Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer
- (2014) Masaki Shiota et al. PROSTATE
- Inhibition of the androgen receptor by mineralocorticoids at levels physiologically achieved in serum in patients treated with abiraterone acetate
- (2014) W Kim et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer
- (2014) Masis Isikbay et al. Hormones & Cancer
- Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
- (2013) Vivek K. Arora et al. CELL
- Inhibition of Protein Kinase C/Twist1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer
- (2013) M. Shiota et al. CLINICAL CANCER RESEARCH
- Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100
- (2012) J. Richards et al. CANCER RESEARCH
- Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression
- (2011) M. Shiota et al. ENDOCRINE-RELATED CANCER
- Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines
- (2009) Andrea Dovio et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started